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Abstract 
Minimally invasive aortic valve replacement aims to preserve the sternal integrity and improve 
postoperative outcomes. In low risk patients, this technique can be achieved with comparable 
mortality to the conventional approach and can result in reduced intensive care and hospital 
length of stay, transfusion requirement, renal dysfunction, improved respiratory function along 
with increased patient satisfaction. In this review we aim to asses if these benefits can be 
transferred to the high risk patient groups. We therefore discuss the available evidence for the 
following high risk groups: elderly patients, re-operative surgery, poor lung function, 
pulmonary hypertension, obesity, concomitant procedures and high risk score cohorts.   
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1. Introduction  
Aortic valve replacement (AVR) via median sternotomy remains the standard treatment for 
aortic valvular disease. However, the development of minimally invasive approaches in general 
surgery has driven the adoption of lesser invasive techniques within the field of cardiac surgery. 
Historically, Cosgrove and Cohn were the first clinicians to pioneer smaller incisions for both 
mitral and aortic procedures(1). Despite longer cardiopulmonary bypass (CPB) times 
compared to conventional surgery (1-13), preservation of the sternal integrity and minimisation 
of dissection may improve the cosmetic result, reduce bleeding, provide better respiratory 
function, yield shorter hospital stays and therefore lower costs and improved patient 
satisfaction. A large meta-analysis by Phan et al. demonstrated that minimally invasive aortic 
valve replacement (mini-AVR) is also associated with a reduced incidence of renal failure and 
has comparable mortality and morbidity to conventional surgery (14). The above advantages 
could prove significant in the “high risk” cohorts such as elderly patients, re-operative surgery, 
poor respiratory status, pulmonary hypertension, renal dysfunction or poor left ventricular (LV) 
function (15, 16). Hence, the current review focuses on the outcomes following mini-AVR in 
the above high risk groups. Although the definition of minimally invasive approach to the aortic 
valve remains a matter of debate, the present review discusses the open approaches, performed 
via a small incision (e.g. not a full sternotomy), therefore we do not refer to the trans-catheter 
aortic valve implantation (TAVI) (17). We included all the studies where the aortic valve was 
approached via a minimally invasive approach including: the various types of partial 
sternotomy, minithoracotomy or port access approach.  
2. Methods 
A thorough literature search was conducted in PubMed and Embase databases, using the 
following search string: “(minimally invasive OR mini OR mini OR minimal access OR partial 
sternotomy OR hemi-sternotomy OR anterior thoracotomy OR parasternal OR transverse 
  
sternotomy) AND (aortic valve) AND (replacement OR surgery OR insertion) AND (high risk 
OR elderly OR old age OR elderly OR left ventricular failure OR left ventricular dysfunction 
OR renal failure OR chronic kidney disease OR renal dysfunction OR chronic lung disease OR 
chronic obstructive pulmonary disease OR re-do OR reoperative OR resternotomy OR 
reintervention OR pulmonary hypertension)”. Further articles were identified by cross 
reference check from the articles identified by our search.  
3. Mini-AVR in Elderly Patients 
The increase in the life expectancy has resulted in more aortic valve surgery being performed 
in the elderly population (18). With an increasing prevalence with age, calcific aortic stenosis 
(AS) is the main valvular disease in the octogenarians with a predicted requirement for 
approximately 3500 AVRs per year (18, 19). Certainly, conventional aortic valve replacement 
(CAVR), performed via full midline sternotomy, remains the definitive treatment and yields 
excellent results (20). However, elderly patients are less able to cope with the stress of surgery 
due to a reduced vital organ reserve and various associated comorbidities (19). Several 
retrospective studies, reported outcomes of mini-AVR versus CAVR in the elderly population 
(Table 1).  
Grossi et. al. (21) compared the outcomes of 166 patients (mean age of 77.5 years) undergoing 
CAVR, with 56 patients (mean age 76 years) undergoing aortic valve replacement using a 
minimally invasive port access technique. There was no difference in hospital mortality. 
However, the minimally invasive group had a lower incidence of sepsis and wound 
complications, decreased fresh frozen plasma transfusion requirement and shorter length of 
hospital stay. 
A prospective study by Sharony et al. (22) matched 189 patients undergoing mini-AVR and 
189 patients undergoing CAVR via sternotomy. All patients were aged over 65, with 28% 
  
being octogenarians. The two cohorts had similar hospital mortalities and similar rates of: re-
intervention, stroke, wound infection, gastro-intestinal complications, new renal failure and 
respiratory failure. The CPB times were similar but the mini-AVR group had a shorter hospital 
stay and more patients were discharged to their own home.  
 
The same group (23) reported results of two propensity-matched cohorts, 233 patients each, 
aged >80 years, undergoing either mini-AVR or CAVR. Hospital mortality and perioperative 
morbidity was similar in both groups. However, a greater proportion of mini-AVR patients had 
a reduced length of hospital stay and were discharged home rather than transferred to a 
rehabilitation facility. In the multivariate analyses, the presence of severe atheromatous aortic 
diseases and need for urgent operation increased the risk of hospital mortality.    
 
El Bardissi (24) et al reported outcomes 249 consecutive mini-AVRs in octogenarians patients 
that were at a prohibitive high risk (median EuroSCORE of 11% and STS score 10.5%) and 
were considered candidates for TAVI. Interestingly, the high cardiac surgery risk scores were 
not predictive of operative mortality which proved to be only 3%. Also the perioperative 
morbidity was low: stroke 4%, renal failure requiring dialysis 1%, cardiac arrest 1 %, sepsis 1 
% and pulmonary embolism 1%. The long-term survival of up to 10 years did not differ from 
a low risk, age and gender matched population.  
 
A retrospective review of consecutive heart operations in patients aged 75 or above, conducted 
by Lamelas et al (25), identified 58 patients that underwent minimally invasive aortic valve 
procedures performed by mini-thoracotomy and compared them with a cohort of 43 patients 
that underwent CAVR. The composite of mortality and morbidity was significantly lower in 
the minimally invasive group. This was due to a lower incidence of renal failure, reduced 
  
intubation time, less wound infection and fewer deaths. Furthermore, the intensive care unit 
length of stay and total length of hospital stay were lower in the mini-AVR group.  
In a small series of 58 isolated mini-AVR performed via a mini sternotomy in patients with 
median age of 76, Alasaar et al (26) reported no operative mortality and no late mortality at 6 
months. There was one reoperation for bleeding, no pacemaker insertion and no wound 
infections. The CPB times were acceptable and the intensive care unit (ICU) mean stay was 
approximately 2 days and the hospital mean stay was 6 days. Similarly, a larger retrospective 
study by Krishna et al. (27) on 255 consecutive mini-AVRs done via mini-right thoracotomy 
in octogenarians, reported acceptable morbidity and mortality rates. 
Santarpino et al (28) allocated 66 patients undergoing sutureless mini-AVR to two age groups: 
age > or = 80 years (25 patients) and age < or = 80 (41 patients). The outcomes in terms of in-
hospital mortality, stroke, pacemaker implantation, survival (mean follow-up of approximately 
14 months) were not different. A health and wellbeing survey questionnaire was conducted 
with no differences reported between the groups.  
Gilmanov et al (29) compared two propensity matched groups of isolated mini-AVRs 
performed via a right anterior thoracotomy (100 patients) versus a full sternotomy (100 
patients). Patients were aged 80 years or above. The main findings of the study were reduced 
stroke incidence, earlier extubation time and shorter hospital stay, favouring the minimally 
invasive group. Both the in-hospital mortality and long term survival at 5 years were similar. 
The rate of postoperative atrial fibrillation (AF) and permanent pacemaker (PPM) insertion 
rates did not differ.  
Moscarelli et al (30) conducted a systematic review of non-randomised studies of 340 elderly 
patients (mean population age above 75) who recieved minimally invasive aortic valve surgery 
versus CAVR  in 343 patients. They found comparable mortality to full sternotomy, 
  
significantly reduced postoperative length of stay, no significant difference in CPB and AoX 
times.  
 
4. Re-do Minimally Invasive Aortic Valve Surgery 
Several studies investigated the potential benefits of minimally invasive surgery in re-operative 
aortic valve surgery (Table 2). Theoretically, a smaller incision would reduce the dissection 
area resulting in less bleeding from adhesiolysis and less risk of damaging patent coronary 
grafts. Furthermore, preservation of the sternal integrity in such high-risk patients improves the 
respiratory function and patient have shown to have shorter hospital stays (32-34). 
In 2000, Byrne et al. (35) reported 34 re-do AVR via partial sternotomy. Sixty-two percent of 
the patients had previous coronary artery by-pass grafting (CABG) while 41% had previous 
valve surgery. There were no intraoperative deaths and no conversions to full sternotomy. The 
early mortality was 5.9% due to arrhythmia in one case and a large stroke in the other case. 
There were no reoperations for bleeding and the median lengths of stays in ICU and hospital 
were 1 and 7 days respectively.  
Sharony et al (36) reported the outcomes of 161 patients undergoing re-do minimally invasive 
valve operations via mini-thoracotomy (61 patients had aortic) versus a 227 patients having 
CAVR via median sternotomy (177 patients). The authors found a significantly lower early 
mortality, no wound infection, less need for transfusion and shorter hospital stays in the 
minimally invasive group. However, the incidence of congestive heart failure, renal disease 
and poor LV function was significantly higher in the sternotomy group. Furthermore, the 
multivariate analysis showed that renal disease and poor ejection fraction were associated with 
increased mortality. The five-year morality was comparable between the two groups. No 
subgroup analysis for the aortic group was performed. 
  
In a smaller series by Bakir et al.(37) of 19 re-do AVR cases done via upper partial sternotomy 
(63.2 % patients with previous coronary CABG) there were no early deaths, however, 4 patients 
(21%) required return to theatre for bleeding including one from an injury to a previous patent 
vein graft. The mean follow-up time was 23.6 months and there were 2 late deaths one of 
unknown cause and one non-cardiac. 
Tabata el al. (38) reported 146 re-do mini AVRs in an elderly population. The majority (93 
patients) had previous CABG. The operative mortality was 4.1%, reoperation rates for bleeding 
was 0.7% and most of the patients required transfusion (83.6%). In this series, there were no 
CABG graft injuries and the five-year actuarial survival was 85%. A small series of 10 patients 
with previous CABG undergoing mini-AVR was also reported by Dell’Amore et al. (39) There 
was no in hospital mortality and no injury to the by-pass grafts.  
Gaeta et al. (40) reported outcomes following re-operative mini-AVR on 16 patients with 
previous patent left internal mammary artery (LIMA) grafts. On this small series there were no 
early deaths but 4 late deaths were reported, out of which 2 were due to cardiac causes. No 
patient required conversion to full sternotomy or reopening for bleeding and there were no 
injuries to the LIMA grafts.  
Mikus et al (41)in a series of 90 patients who underwent reoperative aortic valve surgery 
reported comparative results between a minimally invasive approach cohort (38 patients) and 
a conventional sternotomy cohort (n=52). There were no significant differences between the 
groups in terms of the profile risk (e.g. EuroSCORE, left ventricular function or body mass 
index). There was one death in the minimally invasive group. There were no differences in 
CPB or cross clamp times between the two groups however the partial sternotomy group had 
significantly lower ventilation times.  
  
Kaneko et al.(42) reported outcomes following 105 octogenarians that underwent redo isolated 
AVR. Fifty-one patients underwent mini-AVR while 54 patients had CAVR. Both cohorts had 
similar risk factors. There was no difference in terms of operative mortality or other 
postoperative outcomes between the two approaches, however, the survival analysis at 1 year 
and 5 years favoured mini-AVR.  
Gosev et al.(43) compared the postoperative outcomes of 34 patients undergoing mini-AVR 
with 67 patients undergoing CAVR. Both groups did not differ in terms of demographics or 
preoperative risk profiles. The authors reported shorter operative times, ventilation times, ICU 
stays and hospital length of stays favouring the mini-AVR group. There was one early death in 
the CAVR group. Mid-term survival at 1 year and 5 years favoured mini-AVR.  
Phan et al.(44) in a meta-analysis of 7 observational studies of reoperative mini-AVR found 
similar in-hospital mortality and stroke rates. The rates of PPM implantation, renal failure and 
re-operation for bleeding were again similar. There was no difference in hospital stays between 
the two approaches. 
 
5. Outcomes of mini AVR in patients with high cardiac risk scores 
In the current section we will discuss the studies that reported outcomes of mini-AVR in 
populations considered high risk according to the various risk scoring systems in cardiac 
surgery (Table 3).  
Bridgewater et al (46) reported outcomes of a high risk  cohort (median age 78 and Parsonnet 
score of 18%) who underwent mini-AVR via a transverse sternotomy  approach compared to 
a Parsonnet score, age and sex matched retrospective cohort. The authors found a significantly 
higher mortality, incidence of re-exploration, paravalvular leaks and re-exploration in mini-
  
AVR group. Furthermore, mini-AVR had longer postoperative stays and higher incidence of 
morbidity.  
In 2004, De Smet et al. (47) analysed the outcomes of 100 patients undergoing  mini-AVR via 
J-sternotomy compared to a retrospective series of CAVR performed in 91 patients operated 
before introduction of mini-AVR in that institution. Both cohorts had similar preoperative 
characteristics and they were further stratified by EuroSCORE in low, medium and high risk. 
In the high risk group (EuroSCORE >6) there was a higher incidence of AF in patients 
undergoing sternotomy in contrast to mini-AVR patients who experienced more neurologic 
events. However, when only the severe brain injuries were included in the analysis no 
difference was noted. Similarly, a greater incidence of AF occurred in the medium risk 
sternotomy group. In the low risk mini-AVR patients, there was a higher incidence of AF. 
Overall, the mortality and lengths of stay were similar between conventional sternotomy versus 
mini-sternotomy.  
Grossi et al (48) reported outcomes of isolated AVR in a high risk cohort of 731 patients with 
mean EuroSCORE of 9.7. Mini-AVR was performed in 64.2% (469 patients). No comparative 
analysis was performed between the operative approaches. The actual hospital mortality was 
7.8% suggesting that the EuroSCORE over predicted the mortality. In the multivariate analysis; 
poor ejection fraction, chronic obstructive pulmonary disease (COPD) and peripheral vascular 
disease significantly affected hospital mortality. The five-year freedom from all-cause 
mortality was 72.4% at 5 years. Age, reoperation, renal and chronic lung disease were 
predictors of worse survival.  The authors raised concerns regarding patients referred to TAVI 
based on risk scores that were overestimated, when no long term follow-up outcome is 
available for percutaneous prosthesis.  
  
Zierer et al.(49) compared 21 patients with a mean EuroSCORE of 38% undergoing TAVI with 
cohort of 30 patients with a mean Euro SCORE of 35% undergoing mini-AVR via upper partial 
mini-sternotomy. Allocation was non-randomized; however the perioperative risk profiles 
were matched between the groups. The operative and ventilation times, ICU and hospital length 
of stay were shorter in the TAVI group but there was no difference in early mortality, 
perioperative morbidity and survival at 1 year (100% complete follow-up).  
Martens et al (50) reported outcomes of mini-AVR via partial sternotomy, using the ATS 3F 
Enable sutureless bioprosthesis, in 22 elderly patients. Mean age of 75 years and mean logistic 
EuroSCORE of  13. The mean reimplantation time was 10+/- 6 minutes, CPB time was 87 
minutes and the mean cross clamp time was 55 minutes. The early mortality (<90 days) was 
9% (2 deaths). There were no paravalvular leaks and the implanted valves had low gradients 
both on discharge and at 12 months.  
Later, in 2013, Concistre et al (51) reported outcomes in an elderly population (mean age of 
77) undergoing sutureless aortic valve implantation (3f Enable bioprosthesis) via V-Type 
ministernotomy. The mean EuroSCORE of the cohort was 15%. The mean CPB and aortic 
cross clamp times were 100.2 minutes and 66.4 minutes respectively. One patient had trivial 
paravalvular leak and there were no early deaths or at follow-up (median follow-up time was 
4 months, interquartile range, 2-10 months). The mean pressure gradients were remained low 
on follow-up. Burdett et al.(52) compared two matched cohorts for perioperative profile and 
risk score (mean EuroSCORE of 7). One group (98 patients) underwent manubrium limited 
sternotomy and the other conventional sternotomy (93 patients). The mini-AVR cohort had 
longer CPB times and aortic cross clamp times (10 and 6 minutes respectively) but significantly 
less postoperative blood loss and transfusion requirements. The postoperative morbidity, length 
of stays, rate of paravalvular leaks and in hospital mortality were similar.  
  
Miceli et al. (53) compared the outcomes of mini-AVR using sutureless Perceval S via a right 
minithoracotomy to transapical or transfemoral TAVI between two propensity matched groups 
(37 patients each). The median logistic score of both groups was 14% with a range of 9-20%. 
There were no significant difference in mortality, stroke rates, conversion to sternotomy, and 
bleeding, renal failure or ICU length of stay between the two matched groups. However, mini-
AVR patients had significantly higher length of ward stay while the TAVI patients had more 
paravalvular leaks. There were no differences in the haemodynamic performances of the valves 
between the groups. Medium term survival at 1 year and 2 years was better for the mini-AVR 
groups.  
6. Mini AVR in patients with chronic lung disease or pulmonary hypertension 
As discussed earlier, maintenance of the sternal integrity could prove beneficial in patients with 
reduced respiratory reserve. Calderon et al. (54) in a prospective randomized trial of mini-AVR 
versus CAVR measured the postoperative spirometry parameters in 78 patients. They found no 
significant changes between the two groups.  
Stolinski et al. (55) measured the pulmonary function tests at 1 week, 1 month and 3 months 
of two elderly cohorts (mean age >75 years): mini-AVR (65 patients) versus CAVR (82 
patients). The two cohorts had similar perioperative characteristics. At 1 week and 1 month the 
pulmonary function was better in the mini-AVR but there was no significant difference 
between the two groups at 3 months. The duration of postoperative mechanical ventilation was 
lower in the min-AVR group but the incidence of pulmonary complications was similar.  
A study by Li et al (56) measured the extravascular water index and pulmonary vascular 
permeability index in 90 patients that received either a conventional sternotomy, mini-AVR 
via right anterior thoracotomy or via upper sternotomy. The minimally invasive group had a 
faster recovery of the above parameters.  
  
Only a few studies evaluating the effect of mini-AVR in patients with poor lung function pre-
operatively exist (Table 4). Al Backer et al. (57) in a propensity matched study of 223 patient 
pairs: min-AVR via “J” sternotomy versus AVR via full sternotomy found a shorter ICU and 
hospital length of stay for mini-AVR patients as the forced expiratory volume in 1 second 
(FEV1) decreased. There was a trend towards higher survival of mini-AVR patients (93% 
versus 89% at 1 year, p=0.07) however there was no difference in late survival.  
A retrospective analysis of 165 patients with COPD (82% had moderate COPD e.g. FEV1 
between 50% and 80%) by Santana et al. (58) found no difference in hospital mortality between 
the mini-AVR patients (n=100) and the conventional sternotomy patients (n=65). However, 
the composite of post-operative complications was significantly reduced in mini-AVR groups. 
Furthermore, the ICU lengths of stay and hospital length of stay were shorter in minimally 
invasive group.   
Gosain et al. (59) reported outcomes after mini-AVR in 569 patients with pulmonary 
hypertension. The mean pulmonary artery pressure of the group was 33 mmHg. The overall 
early mortality was 3.5% and the stroke rates were 1.4%. Patients with severe pulmonary 
hypertension had a significantly longer ICU stay and trend towards longer ventilation times. 
7. Mini AVR in patients with renal dysfunction 
Pre-operative renal dysfunction is an independent risk factor in operative mortality and late 
survival in patients undergoing heart surgery (60). The reno-protective effect of minimally 
invasive surgery has already been proven in mitral valve surgery (61, 62). 
We found only 2 studies that evaluated the effect mini-AVR in patients with pre-existing renal 
dysfunction (Table 4).  Valdez et al.(63) retrospectively reviewed a cohort of 688 patients with 
chronic kidney disease stages 2-5. In their study, 236 patients received a mini-AVR and 87 
received a conventional AVR. There were no differences in operative mortality between the 
  
minimally invasive or the full sternotomy groups. The minimally invasive surgery group had a 
lower incidence of acute on chronic kidney injury despite longer CPB and aortic cross clamp 
(AoX) times. However, there was no difference in the peak postoperative creatinine 
measurements between the two groups or the need for dialysis. The authors used the RIFLE 
(Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) classification to 
define AKI. This classification also takes into account urine output and the estimated 
glomerular filtration rate.  Furthermore, the minimal access patients had fewer composite 
complications, shorter ICU and hospital lengths of stay. In the multivariate analysis minimally 
invasive surgery was associated with 60% reduction in the risk of development of acute kidney 
injury. Similar results were found by a large meta-analysis of non-randomized controlled trials 
where renal failure occurred less in the mini-AVR group despite longer CPB and AoX times 
(14). 
Haldewang et al.(64), in a small retrospective study compared 77 patients that received a mini-
AVR to 56 patients that received a TAVI. The mini AVR patients had a lower risk of 
developing acute kidney injury compared to TAVI. 
8. Patients with poor left ventricular function or severe heart failure 
The study by Tabata et al. (65) is the only one to date that compares the effect of mini-AVR 
versus CAVR in patients with pre-operative LV dysfunction. The authors propensity matched 
two cohorts of 41 patients each (mini-AVR or CAVR). There was no significant difference in 
operative mortality, post-operative complications, blood transfusion requirement or length of 
hospital stay and CPB and AoXtimes. 
A study conducted by Mihaljevic et al (66)  compared two propensity marched cohorts of 
patients with severe heart failure (New York Heart Association III and IV): minimally invasive 
valve surgery versus conventional sternotomy valve surgery. The mean ejection fraction did 
not differ between the groups and was classed as moderate. The comparisons were adjusted not 
  
only to the patient characteristics but also to the individual surgeon. Without adjusting for the 
operator, the CPB, aortic cross clamp times and ICU length stays were shorter for the minimally 
invasive group. The hospital mortality, long term survival and were similar. However, when 
adjusting for the surgeon there were no differences in the outcomes between the two groups. 
 
9. Mini AVR in obese patients 
Several studies found no adverse outcomes of performing conventional cardiac surgery in 
obese patients. However, this group of patients is at increased risk of deep sternal wound 
infection, therefore a minimally invasive approach could prove advantageous (58, 67). In 
contrast, adequate exposure using a minimally invasive approach can prove to be a challenge. 
Two studies to our knowledge evaluated the effect of mini-AVR in this high-risk group (Table 
4). Santana et al (58) compared the outcomes of 31 patients who had aortic valve surgery via a 
mini-thoracotomy with a matched group 43 patients had aortic valve surgery full sternotomy. 
The composite of postoperative complications occurred less frequently in the minimally 
invasive group. This was driven by a lower incidence of renal failure, shorter ventilation times, 
lower reintubation rates, lower incidence of deep sternal wound infection and reduced in-
hospital mortality. A recent study by Acharya et al.(68) on 90 patients who underwent mini-
AVR compared using univariate regression analysis on the effect on postoperative outcomes 
of a BMI (body mass index) <25 (in 36 patients) with the effect of BMI≥25 (54 patients). The 
high BMI cohort had increased incidence of hospital acquired pneumonia and new onset of 
AF. However, there was no difference in ICU length of stay, hospital length of stay, wound 
complications rates, inotrope requirements or renal dysfunction. Furthermore, a correlation 
between increasing BMI and reduced ventilation or post-operative blood loss was found. 
 
 
  
10. Mini-AVR in patients requiring concomitant procedures 
Another high-risk group is that of patients requiring additional, complex procedures associated 
to minimally aortic valve surgery. 
Totaro et al. (69) reported the outcomes of 1126 procedures performed via upper mini-
sternotomy. The authors compared the outcomes of isolated min-AVR (61%) with re-do mini 
AVR (7%) or other complex cardiac surgery (32%) including AVR combined with aortic 
surgery procedures or CABG. The complex cardiac surgery group had a higher operative 
mortality, longer ventilation times and longer ICU status however the surgical revision rates 
were similar in all 3 groups. 
Kaneko et al. (70) reported outcomes of mini-AVR via an upper hemi-sternotomy in 119 
patients who required a concomitant aortic procedure. The majority of the patients (59.6%) had 
supra-coronary ascending aorta replacement. The authors reported an operative mortality of 
2.8% and a postoperative survival at 1 and 5 years of 96.2% and 92.4% respectively. There 
were 4 (3.7%) reoperations for bleeding. Other complications included postoperative renal 
failure in 2 cases and myocardial infarction in 2 other cases. The mean length of stay was 
approximately a week. 
Elmahdy et al. (71) reported a case series of 6 patients that had triple valve surgery via a right 
anterior mini-thoracotomy. All patients had aortic valve surgery, mitral valve repair and 
tricuspid valve repair. The authors reported 2 early deaths and 2 cases of postoperative AF. 
11. Limitations of the current evidence 
 
The evidence presented in the current review suggests that minimally invasive aortic valve 
surgery in the various high risk categories is done with comparable survival to conventional 
techniques but with several additional benefits. However, we have to acknowledge several 
  
limitations to the conclusions we draw. Firstly, all the studies we found were single centre, 
non-randomized, retrospective and the majority suffered from a small patient sample size. 
Furthermore, both the patients and medical staff were not blinded to the treatment modality. 
Efforts were made to balance the groups by propensity matching or cardiac risk score matching 
in the comparative studies, but this does eliminate patient selection bias entirely. The weight 
of the evidence suggested a clear decrease in hospital stays with minimally invasive techniques 
however this is again subject to bias depending on the grade of doctor making the discharge 
decision at that time. The aim of this review was to look at the outcomes after minimally 
invasive aortic valve surgery; however some studies included mixed series of aortic and other 
valve surgery that lacked sub-analysis for aortic procedures. Finally, there was heterogeneity 
in the type of minimally invasive approach used that could influence the outcomes.  
 
 
 
 
 
 
 
 
 
 
 
  
12. Conclusions 
 
All the current evidence on the performance of mini-AVR in high risk patient groups is based 
on retrospective, observational studies. In all high-risk groups, mini-AVR is performed with 
comparable morality and mid-term survival to conventional surgery.  In elderly patients, 
despite longer aortic cross clamp times and CPB times, mini-AVR results in improved 
ventilatory function and renal function, reduced wound infection, shorter hospitalization and a 
greater proportion of patient being discharged straight to home. Re-do mini-AVR is a safe 
procedure with some studies showing a benefit in mid-term survival. Mini-sternotomy in 
patients with previous CABG can be performed with a low risk of injury to patent grafts. 
Current cardiac surgery scoring systems tend to overestimate mortality in high risk patients. 
Despite longer operative times and longer hospitalization, sutureless mini-AVR is a 
competitive alternative to TAVI in the high-risk patient resulting in less paravalvular leaks 
according to a study. In patients with chronic lung disease, pulmonary hypertension or chronic 
kidney disease, a minimally invasive approach is safe and reduces hospital and ICU length of 
stays. Obese patients can benefit from a minimally invasive approach in terms of reduced 
wound complications, improved respiratory function and improved survival according to a 
study. Mini-AVR concomitant with aortic surgery or valve surgery can be performed with 
acceptable mortality and morbidity.   
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Table 1 Mini-AVR in Elderly patients 
Abbreviations: Abbreviations: AVR- aortic valve replacement; mini-AVR- minimally invasive aortic valve replacement; SS – standard 
sternotomy; CAVR- conventional aortic valve replacement via median sternotomy; CPB – cardiopulmonary by-pass; A0X – aortic cross clamp; 
IQR – interquartile range; ICU – intensive care unit; AKI – acute kidney injury; PPM – permanent pacemaker; AF- atrial fibrillation.  
Author, 
date 
Study type 
and level of 
evidence  
Patient groups and 
study design 
Minimal 
access 
approach 
Outcomes  Comments Author’s 
conclusions 
Grossi et 
al., 1998 
(21) 
Retrospective, 
Level III 
259 patients (mean 
age 77.5 years) had 
standard sternotomy 
(SS); 111 patients 
minimally invasive 
port access mean 
age 76.0 years); 166 
(64.1%) patients had 
aortic valve 
replacement via SS 
while 56 (50.4%) 
had AVR done via 
minimally invasive 
port access 
approach.  
port access hospital mortality: 9.7% (25/259) in 
conventional group and 7.2% 
(8/111) in mini-AVR group (p = 
0.50); mini-AVR: significantly 
lowered incidence of sepsis or 
wound complications (1.8% vs 
7.7%; p = 0.027), required less fresh 
frozen plasma transfusion, (median 
1-unit vs 2 units; p=0.04) and had a 
shorter stay (11.6 days vs 17.6 days; 
p = 0.001) 
mixed series of 
aortic and 
mitral surgery; 
mitral surgery 
was performed 
significantly 
more often in 
the minimally 
invasive group 
((49.5% vs. 
35.9%; p=<0 
.001)  
mini-port AVR 
yields excellent 
results in elderly 
and is 
associated 
significantly 
less plasma 
transfusion, 
fewer 
postoperative 
complications, 
and shorter 
length of 
hospital stay. 
Sharony et 
al., 2003 
(22) 
Prospective, 
propensity 
matched, 
Level III 
189 mini-AVR 
patients were 
matched with 189 
CAVR patients by 
age, 
ventricular function, 
valvular pathology, 
urgency of 
operation, diabetes, 
right 
anterior 
mini-
thoracotomy 
no difference in hospital mortality 
(6.9%) and freedom from 
postoperative morbidity, mini-AVR 
versus CAVR (82.5% versus 81.5%, 
p=0.79); in multivariate analysis: 
urgent procedures [Odds Ratio (OR) 
3.97; p=0.03], congestive heart 
failure (OR 3.94; P 0.03), and 
ejection fraction  30% (OR 4.16; P 
 
mini-AVR is 
safe in elderly 
patients, with 
morbidity and 
mortality 
comparable 
to SS and is 
associated with 
shorter stay and 
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previous cardiac 
surgery, renal 
disease, and 
history of stroke. All 
patients were above 
80 years. 
0.03) were predictors of hospital 
mortality and prolonged length of 
stay was associated with age 
(p=0.05),  stroke (OR 3.5,p=0.001), 
congestive heart failure (CHF) (OR 
2.2, p=0.004), and SS (OR 
2.3,p=0.002). Mini-AVR patients 
were discharged home (52.6% 
versus 38.6%, P 0.03) rather than to 
rehabilitation facilities; no difference 
in survival at 3 years.  
more patient 
discharged 
home.  
Sharony et 
al., 2004 
(23) 
Retrospective, 
propensity 
matched 
Level III 
2 matched cohorts 
of 233 mini-AVR 
and 223 CAVR. 
Matching variables 
included left 
ventricular ejection 
fraction <30%, 
previous myocardial 
infarction, 
congestive heart 
failure, previous 
cardiac surgery, 
renal insufficiency, 
age, gender, chronic 
obstructive 
pulmonary disease 
(COPD), peripheral 
vascular disease, 
previous stroke or 
carotid disease, 
urgent/emergent 
right 
anterior 
mini-
thoracotomy 
hospital mortality mini-AVR vs SS 
groups: 5.6% 
versus 7.3% (p = 0.45) and 
morbidity: 13.3% versus 14.2% (p = 
0.79); multivariable analysis: 
mortality associated with: severe 
atheromatous aortic disease (p = 
0.001), chronic obstructive 
pulmonary disease (COPD) (p 
=0.002), and urgent operation (p = 
0.02); freedom major perioperative 
morbidity (86.7% versus 85.8%; p = 
0.79); median length of stay was 
shorter with 
mini-AVR (6 versus 8 days; p 
<0.001); greater proportion of mini-
AVR patients than SS patients was 
discharged home rather than sent to 
rehabilitation facilities or nursing 
homes (65.7% versus 52.9%; p = 
0.05). 
 
mini-AVR 
results in 
comparable 
mortality or 
morbidity to 
CAVR and is 
associated with 
shorter stay and 
more patients 
being 
discharged 
home.  
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operation, valvular 
pathophysiology, 
and atheromatous 
aortic disease 
Elbardissi 
et al., 2011 
(24) 
Retrospective, 
Level III 
249 mini-AVR in  
octogenarians [84±3 
(range 80–95)], 
European System 
for Cardiac 
Operative Risk 
Evaluation 
(EuroSCORE) and 
Society of Thoracic 
Surgeons score used 
for risk stratification 
(STS) 
upper 
sternotomy 
operative mortality was 3% (n 
=8/249); median modified 
EuroSCORE (11%; interquartile 
range, 6–14) and STS score (10.5%; 
interquartile range, 7–17) were not 
predictive of 30-day mortality 
(EuroSCORE c-index= 
0.527,p=0.074, STS score c-
index=0.67, p=0.18); long-term 
survival after minimally invasive 
aortic valve replacement at 1, 5, and 
10 years was 93%, 77%, and 56%, 
respectively with no significant 
difference in long-term survival 
compared with that of a US age- and 
gender-matched population 
(standardized mortality ratio, 1.01; 
95% confidence interval, 0.76–1.37; 
p=0.88); in multivariate analysis: 
increasing age (hazard ratio, 1.10; P 
¼ .008) and severe COPD (hazard 
ratio, 2.52; P<.007) were significant 
predictors of survival 
 
excellent 
outcomes after 
mini-AVR with 
long-term 
survival that is 
no different than 
that of an age 
and 
gender-matched 
US population. 
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Lamelas et 
al., 2011 
(25) 
Retrospective, 
Level III 
consecutive patients 
age > 75 years: 119 
mini-AVR versus 84 
who had CAVR 
right 
anterior 
mini-
thoracotomy 
median postoperative length (mini-
AVR vs SS groups)=7 days 
(interquartile range [IQR] 6 to 
10)versus 12 days (IQR 9 to 20), 
p<0.001; intensive care unit (ICU)  
length of stay  (mini-AVR vs SS 
groups) was 52 hours (IQR 44 to 93) 
versus 119 hours (IQR 57 to 193), 
p<0.001; in-hospital mortality  
(mini-AVR vs): 2 (1.7%) versus 8 
(9.5%, p =0.01 and composite 
postoperative morbidity and 
mortality occurred in 25 (21%) 
versus 38 (45.2%), p<0.001; 
difference in in the composite of 
mortality or morbidity driven by: 
acute renal failure, 1 (0.8%) vs 14 
(16.7%), p<0.001; intubation 
(hours): 23 (19.3%) vs 32 (38.1%), p 
=0.003; wound infections: 1 (0.8%) 
vs 5 (6%), p =0.034; and death 8 
(9.5) vs 2 (1.7), p=0.01; 
Cardiopulmonary bypass time 
(CPB), IQR, (mini-AVR vs SS 
groups): 118 (67–186) vs 86 (39–
268),  p<0.001; Cross-clamp (AoX) 
time; 84 (40–154) vs 61 (25–156), 
p<0.001 
,  lower morbidity 
and mortality of 
mini-AVR in 
elderly 
compared to SS.  
Alassar et 
al., 2013 
(26) 
Retrospective, 
Level III 
58 patients (76.1 ± 
9.4 years) who had 
mini-aVR 
hemi-upper 
sternotomy 
AoX: 54.6 +/−6.3 min, CPB time: 
71.2+/−11.3, time of surgery: 154.1 
+/−26.8 min, Re-operation for 
bleeding: 1 case (1.7%); no strokes 
single arm 
study 
mini-AVR safe 
in the elderly. 
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or pacemaker implantations needed, 
mean ventilation time=4.5 hours; 
mean ICU stay=2 days; mean length 
of hospital stay=6 days; no mortality, 
sternal  
Santarpino 
et al., 2013 
(31) 
Prospective, 
Level III 
66 patients mini-
AVR with sutureless 
Perceval S 
bioprosthesis 
allocated to age 
group ≥80 years 
(n=25) or age group 
<80 years (n=41) 
 
length of intensive care unit stay was 
similar in both groups (age ≥80 vs 
<80): 1.9 ± 0.8 vs 2.5 ± 1.4 days, p = 
0.061; in-hospital mortality occurred 
in only one patient aged ≥80 years; 
transient cerebral ischemic similar in 
age ≥80 vs <80, p = 0.59; no 
difference in pacemaker 
implantation (1.5 versus 3%; p = 
0.68), 2 patients age ≥80 versus 1 
patient age<80 died during a mean 
follow up was 13.9 ± 7.4 months, no 
significant differences between 
groups in SF-36 questionnaire 
answers. 
Mean 
EuroSCORE 
greater in age 
group ≥80 
years (12.3 ± 
7.1 vs 7.7 ± 
3.8, p=0.002  
mini-AVR 
results 
comparable for 
in patients aged 
≥80 years were 
comparable to 
those of 
younger 
patients. 
Krishna et 
al., 2014 
(27) 
Retrospective, 
Level III 
Mini-AVR in 255 
consecutive patients 
with a mean age 
83.5 ± 3 years 
right 
anterior 
mini-
thoracotomy 
4 patients (1.6%) had 
cerebrovascular accidents, 38 
(14.9%) prolonged ventilation, 4 
(1.6%) reoperation for bleeding, and 
8 (3.1%) acute kidney injury; median 
intensive care unit length 
of stay =48.5 hours (IQR 27-92 h) 
and the postoperative 
length of stay=7 days (IQR 5-9 
days); 30-day 
mortality=3.1% (n = 8), combined 
end point of morbidity and mortality 
single arm 
study;  
3 cases were 
re-do. 
Mini-AVR can 
be performed 
safely in the 
elderly with 
acceptable 
outcomes.  
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19.2% (n = 49), all-cause mortality 
at 1 year=6.7% and at 3 years 10.2%. 
Gilmanov 
et al., 2015 
(29) 
Retrospective, 
propensity 
matched 
Level III 
patients aged 80 
years, propensity 
score matching: 100 
mini-AVR vs 100 
SS 
right 
anterior 
mini-
thoracotomy 
no difference in operative times, 
mini-AVR patients had a larger 
prosthesis (p < 0.001) and were more 
likely to receive a sutureless valve 
(p< 0.001); shorter time for 
extubation 
(p < 0.001) and shorter hospital 
length of stay (p = 0.005) for mini- 
AVR, no difference in transient 
ischaemic attack (p = 0.47), more 
postoperative strokes in CAVR [0 vs 
4 (4.0%) (P = 0.043)], no differens in 
pacemaker (p = 0.47) or new-onset 
of atrial fibrillation (p = 0.28), no 
difference in operative mortality (p = 
0.68), mini-AVR more likely to be 
discharged straight to home (p = 
0.031), similar survival rates (mini-
AVR vs SS) at 5 years (80 vs 81%, P 
= 0.37), minimally invasive 
approach no impact on survival (p = 
0.38). 
the median 
follow-up 
duration was 
longer in the 
SS group (59 
vs 24 months, p 
< 0.001) 
Mini- AVR 
safely 
performed in 
patients aged 
≥80 years and 
associated with 
lower 
postoperative 
stroke 
incidence, 
earlier 
extubation and 
shorter hospital 
stay. 
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Moscarelli 
et al., 2016 
(30) 
meta-analysis 
of non-
randomized 
studies, Level 
II 
1347 patients (675 
conventional 
standard sternotomy 
and 672 minimally 
invasive valve 
surgery) 
right 
anterior 
mini-
thoracotomy 
or upper 
sternotomy  
comparable early mortality to 
standard sternotomy (odd ratio (OR) 
0.79, CI [0.40,1.56], p=0.50) with no 
heterogeneity (p=0.13); mini-AVR 
associated with reduced intubation 
time (OR 0.48, CI [0.30,0.78] and 
reduced post-operative length of stay 
(weighted mean difference (WMD) -
2.91, CI [-3.09, -2.74] p<0.00001); 
CPB times and (WMD 24.29, CI 
[22.97, 25.61] p<0.00001 and AoX 
times (WMD 8.61, CI [7.61, 9.61], 
p<0.00001) were longer for 
minimally access valve surgery 
pooled 
outcomes for 
aortic and 
mitral valve 
surgery; 
subgroup 
analysis 
demonstrated 
statistically 
significant 
reduced post-
operative 
length of stay 
for both 
minimally 
invasive aortic 
and mitral 
surgery 
mini-AVR or 
minimally 
invasive mitral 
surgery 
associated with 
longer CPB and 
AoX times but 
shorter 
intubation and 
lengths of stay.  
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Table 2 Re-do mini-AVR 
Abbreviations: Abbreviations: AVR- aortic valve replacement; mini-AVR- minimally invasive aortic valve replacement; SS – standard 
sternotomy; CAVR- aortic valve replacement via median sternotomy; CPB – cardiopulmonary by-pass; A0X – aortic cross clamp; IQR – 
interquartile range; ICU – intensive care unit; AKI – acute kidney injury; PPM – permanent pacemaker; AF- atrial fibrillation.  
Author, 
date 
Study type 
and level of 
evidence 
Patient group Minimal 
access 
approach 
Previous 
cardiac 
surgery 
Outcomes Comments Author’s 
conclusions 
Byrne et 
al., 2000 
(45) 
Retrospective. 
Level III 
34 mini-AVRs, 
23 (66%) 
underwent AVR 
of the native 
aortic valve and 
11 (33%) 
underwent 
replacement of a 
prosthetic valve.   
upper re-
sternotomy 
(inverted 
"T") 
21 patients 
(62%) had 
previous 
coronary 
artery 
bypass 
grafts 
(CABG) and 
14 (41%) 
had previous 
valve 
surgery 
no intraoperative or 
valve-related 
complications; no 
conversion to full re-
sternotomy; 2 (5.9%) 
early deaths: 1 
arrhythmia and 1 stroke; 
no reoperation for 
bleeding; morbidity: 3 
(9%) new onset atrial 
fibrillation (AF), 3 
pacemaker 
implantations (9%), 2 
deep sternal wound 
infections (6%); median 
ICU stay: 1 day; median 
hospital stay: 7 days; at 
follow-up (100 % 
complete, median 19 
months): 1 (3%) late 
deep sternal wound 
 
mini-AVR 
associated 
with low 
morbidity 
and 
mortality.  
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infection, 2.32 (6%) late 
cardiac deaths  
Sharony et 
al., 2006 
(36) 
Retrospective. 
Level III 
161 patients via 
mini-thoracotomy 
for valve surgery 
(aortic = 61; 
mitral = 100) 
compared with 
337 patients who 
had valve surgery 
via SS 
(aortic = 160; 
mitral = 177) 
right anterior 
mini re-
thoracotomy 
not specified hospital mortality was 
lower for mini-AVR: 
5.6% (9/161) versus 
11.3% (38/337) 
(univariate, p=0.04); 
mean CPB time 
(p=0.15) and Aox times 
similar (0.45), no 
difference in stroke 
rates (p=1.00); deep 
wound infection rates  
wound infections (0% 
vs 2.4%, p = 0.05), less 
transfusion (p=0.02) and 
shorter hospital stay 
(p=0.009) in mini-AVR 
patients; higher 5-year 
survival with mini-AVR 
(92.4 ± 2% vs 86.0 ± 
2%, respectively, p = 
0.08) 
incidence of 
congestive heart 
failure, renal 
disease, and non-
elective 
procedures were 
higher in the SS 
group; in 
multivariate 
analysis (odds 
ratio: 95% 
confidence 
intervals, p value): 
COPD (p = 
0.001), renal 
disease (p=0.01), 
cerebrovascular 
disease (p=0.04), 
and ejection 
faction<30% (p = 
0.06) associated 
mini-AVR 
yields less 
hospital 
morbidity, 
decreased 
hospital 
length of 
stay, and 
slightly 
favourable 
mid-term 
survival 
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with increased 
mortality. 
Bakir et 
al., 2007 
(37) 
Retrospective. 
Level III 
19 consecutive 
patients who had 
mini-AVR 
J-sternotomy CABG: 12 
patients 
(63.2%) and 
aortic valve 
surgery, 6 
patients 
)31.5%) 
Mean CPB:133.1 ± 54.4 
and mean AoX: 87.4 ± 
32.7; mean intubation 
time was 1.5 ± 1.4 days, 
mean ICU stay: 2.9 ± 
2.6; mean hospital 
stays: 12.9 ± 5.7 days, 
median chest drain 
output: 550 ml, 4 
revisions for bleeding; 2 
hospital deaths (5%), 1 
sternal wound infection, 
3 patients had new-
onset AF 
single arm study re-do mini-
AVR 
feasible 
procedure 
with 
avoidance of 
injury to 
previous 
coronary 
grafts 
Tabata et 
al., 2008 
(38) 
Retrospective. 
Level III 
146 patients, 
minimally 
invasive aortic 
valve surgery 
upper re-
sternotomy  
109 patients 
CABG 
(patent 
internal 
thoracic 
artery graft 
in 93 
patients, 
63.7%), 
Median CPB: 150 
minutes; mean AoX: 80 
minutes; 4 patients: 
conversion to full 
sternotomy; operative 
mortality was 4.1% 
(6/146); reoperation for 
bleeding: 0.7% (1/146); 
blood transfusion: 
More than 1 
previous operation 
in 13 (8.9%); 19 
patients (13%) 
underwent 
concomitant 
procedures: 
CABG, mitral 
valve repair or 
re-do mini-
AVR 
feasible and 
safe 
procedure 
with 
avoidance of 
injury to 
previous 
  29 
previous 
AVR: 33 
(22.6%) 
83.6% (122/146), no 
coronary graft injuries; 
median hospital stay: 8 
days; 56% (79/140) 
patients discharged 
home, 5-year actuarial 
survival was 85%. 
ascending aorta 
replacement 
coronary 
grafts 
Dell'Amore 
et al., 2009 
(39) 
Retrospective. 
Level IV 
10 mini-AVR 
patients 
upper j-
shaped mini 
re-
sternotomy 
All patients 
had previous 
CABG with 
all grafts 
patent.  
no in-hospital mortality, 
no conversions to full 
re-sternotomy, no 
damage to previous 
grafts, no perioperative 
MI, 1 patient required 
pacemaker insertion.  
 
mini-AVR 
in patients 
with 
previous 
coronary 
bypass 
grafting can 
be 
performed 
safely and 
decreased 
risk of 
injury to 
coronary 
grafts.   
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Gaeta et 
al., 2010 
(40) 
Retrospective. 
Level III 
16 patients that 
had mini-AVR 
J mini-re-
sternotomy 
in 15 patients 
and inversed 
“T” mini-re-
sternotomy 
in 1 patient.  
16 patients 
wih previous 
CABG and 
patent LIMA 
to LAD 
graft. 
Mean CPB time was 
119.7 ± 38.1 minutes 
(range: 50–235); Mean 
AoX time was 72 ± 20 
minutes (range:45–125); 
No damage to LIMA; 
no intra- or 
perioperative 
myocardial infarction 
(MI), no conversions to 
full re-sternotomy; no 
reoperations for 
bleeding; blood 
transfusion required in 7 
patients; Mean  ICU 
stay: 1.6 ± 1.1 days; 
mean postoperative 
hospital stay was 7.5 ± 
2.6 days; follow-up was 
100% complete in 
(median 58 months, 
range 11–124): 4 late 
deaths (2 cardiac 
related); no prosthesis-
related morbidity; 
survival at 1, 5, and 10 
years is 91.6%, 83.3% 
and 75%, respectively 
 
mini-AVR 
feasible in 
patients with 
previous 
patent 
LIMA to 
LAD graft.  
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Mikus et 
al., 2013 
(41) 
Retrospective. 
Level III 
90 patients who 
underwent 
reoperative AVR: 
38 mini-aVR and 
52 SS.  
upper j-
shaped mini 
re-
sternotomy 
46 had 
patent 
bypass grafts 
and 44 
previously 
had heart 
valve 
replacement 
or repair. 
median (IQR) CPB and 
AoX for mini AVR 
group were: 67 (28) min 
and 51 (28) min 
respectively vs 72 (47) 
min 
and 53.5 (28) min for 
SS (p = 0.686 and p = 
0.993); ventilation time 
was less with mini-AVR 
(p = 0.027). Mortality 
for mini-AVR: 1 (2.6%) 
vs 3 (5.8%), p=0.476.  
16 patients had 
endocarditis as the 
etiology, and 14 
had prosthetic 
valve 
endocarditis.  
Mini-AVR 
at least as 
safe as the 
standard 
procedure in 
terms of 
hospital 
morbidity 
and 
mortality 
rates 
Kaneko et 
al., 2014 
(42) 
Retrospective. 
Level III 
105 patients, 
aged > 80 years, 
isolated valve 
surgery only: 51 
mini AVR and 54 
SS.  
upper hemi 
re-
sternotomy 
 
6 patients (5.7%) had 
reoperation for 
bleeding, 4 (3.8%) 
permanent stroke, 4 
(3.8%) new renal 
failure, 22 (21.0%) new-
onset 
atrial fibrillation; 
operative mortality was 
9.2% in the SS group 
and 3.9% in the mini-
AVR group (p=0.438); 
survival benefit 
at both 1 year 
(79%±11.7% vs 
92%±7.8%) and 5 years 
(38%   ±17.6% vs 
65%±15.7%, p=0.028). 
no differences in 
the preoperative 
risk profiles of the 
two cohorts; 
regression 
analysis identified 
heparin-induced 
thrombocytopenia, 
reoperation for 
bleeding, older 
age, full 
sternotomy, and 
an infectious 
complication as 
predictors of 
mortality 
acceptable 
in-hospital 
outcomes 
and 
operative 
mortality for 
re-do mini-
AVR in 
high risk 
cases; 
survival 
benefit in 
mini-AVR 
patients.  
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Gosev et 
al., 2015 
(43) 
Retrospective. 
Level III 
101 patients, 
isolated valve 
surgery: 34 mini 
AVR and 67 SS 
upper hemi-
sternotomy 
All patients 
had previous 
AVR: 57 
were 
bioprosthesis 
and 44 
mechanical; 
shorter operative for 
mini-AVR vs SS: 330 
min vs 356 min, p = 
0.053; mini-AVR 
patients had shorter 
ventilation time (5.7 h 
vs 8.4 h; p 
= 0.005), ICU stay (37 h 
vs 63 h; p ≤ 0.001) and 
hospital length of stay 
(6.5 days vs 8.0 days; p 
= 0.038); operative 
mortality: 1 SS and 0 
mini-AVR; survival at 1 
and 5 years for mini-
AVR versus SS: 100% 
(95% CI 100100) and 
100% (95% CI 100100) 
vs 93.9% (95% CI 
88.299.7) and 85.0% 
(95% CI 75.194.9), 
respectively (p = 0.041). 
 
Mini-AVR 
offers 
shorter 
hospital 
stay, 
improved 
mid and 
long term 
survival 
compared to 
conventional 
approach.  
Phan et al., 
2014 (44) 
Meta-
analysis, 
Level II 
441 mini-AVR 
patients from 11 
studies.   
various: 
upper mini-
sternotomy, 
“J” mini-
sternotomy, 
mini-
thoracotomy, 
upper mini-
sternotomy 
(“T” and L) 
In-hospital 
mortality 
in hospital mortality 0-
9.5%, no difference 
mini-AVR vs SS (RR, 
0.77; 95% CI, 0.39-
1.54; P=0.46); similar 
stroke rates: 2.6-8%; no 
difference in rates of 
pacemaker 
implantation, renal 
failure and reoperation 
Meta-analysis of 
observational 
studies (4 single 
arm and 7 
comparative) 
mini-AVR 
similar 
efficacy and 
mortality 
outcomes 
compared to 
SS 
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for bleeding; similar 
CPB durations and AoX 
times; no difference in 
hospital stays.  
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Table 3 Mini-AVR in patients with high cardiac surgery risk score 
Abbreviations: AVR- aortic valve replacement; mini-AVR- minimally invasive aortic valve replacement; SS – standard sternotomy; CAVR- 
aortic valve replacement via median sternotomy; CPB – cardiopulmonary by-pass; A0X – aortic cross clamp; IQR – interquartile range; ICU – 
intensive care unit; AKI – acute kidney injury; PPM – permanent pacemaker; AF- atrial fibrillation.  
Author, 
date 
Study type and 
level of evidence 
Patient group Cardiac 
Risk Score 
Minimal 
access 
approach 
Outcomes Comment Conclusions 
Bridgewater 
et al., 1998 
(46) 
Retrospective, 
level IV 
14 patients 
(median age 
78) mini-
AVR patients 
compared 
with a 
historical 
CAVR group 
(n=14). 
Mean 
Parsonnet 
score of 18% 
Transverse 
sternotomy 
AoX and CPB times 
(67 minutes and 92 
minutes for mini-
AVR versus 
46minutes and  66 
minutes respectively 
for SS AVR, 
p=0.001); hospital 
stay; median 12 days 
for mini-AVR vs 8 
days for SS AVR, P = 
0.025; 2 deaths vs 0 
(p=0.16) in the mini-
AVR group, in the 
mini-AVR group: 2 
re-explorations for 
bleeding, 3 new 
paravalvular leaks 
compared to none in 
the control group 
(p=0.07), 1 patient 
Patients 
matched for 
surgeon, age, 
sex and 
Parsonnett 
score.  
A greater level of 
morbidity and 
mortality is 
associated with 
mini-AVR 
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had CVA and 1 
patient had 
respiratory failure; in 
the control group 
there was 1 patient 
with new onset of 
renal failure and  1 
wound dehiscence.  
De Smet et 
al., 2004 
(47) 
Retrospective 
study, Level III 
100 patients 
mini-AVR 
and 99 
patients SS 
AVR; 
Patient 
stratified into 
low, medium 
and high risk 
groups 
according to 
EuroSCORE; 
high risk 
patients: 51 
mini-aVR vs 
40 SS AVR. 
J-shaped 
mini-
sternotomy 
In the high risk 
group: more CAVR 
patients had new 
onset AF: 15 (29.4%) 
vs 21 (52.5%), 
p=0.001 while more 
neurological events 
occurred in the mini-
aVR group: 3 (5.8%) 
vs 1 (2.5%), p=0.001; 
no differences in 
terms of mortality, 
sternal or other 
infection. 
overall no 
differences in: 
AoX time, 
CPB time, 
ICU blood 
loss, ICU and 
hospital stays. 
In high risk 
patients using a 
minimally 
invasive approach 
proves beneficial 
in terms of 
cardiac rhythm 
disturbance. 
Grossi et 
al., 2008 
(48) 
Retrospective 
study, Level III 
731 patients 
with 
EuroSCORE 
of 7 or higher 
undergoing 
isolated mini-
aVR 
mean 
EuroSCORE 
was 9.7 
(median, 10), 
and the mean 
logistic 
EuroSCORE 
was 17.2%. 
right anterior 
mini 
thoracotomy 
in 436 
(92.9%), 
upper mini-
sternotomy 
approach in 
33 (7.1%) 
actual hospital 
mortality was 7.8% 
(57 of 731); in 
multivariate analysis: 
ejection fraction of <  
30 % (p =0.002; odds 
ratio [OR], 3.13), 
chronic obstructive 
pulmonary disease 
(p=0.019; OR, 2.14), 
single arm 
design 
Logistic 
EuroSCORE 
greatly over 
predicts mortality 
in these patients 
that could benefit 
from mini-AVR 
rather than TAVI. 
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and peripheral 
vascular disease 
(p=0.048; OR, 2.13) 
were predictors of 
hospital mortality; 
freedom from all-
cause death 
(including hospital 
mortality) was 72.4% 
at 5 years (152 
patients); age (p< 
0.001), previous 
cardiac operations (p 
< 0.014; OR, 
1.51), renal failure (p 
< 0.002; OR, 2.37), 
and chronic 
obstructive 
pulmonary disease (p 
< 0.007; OR, 1.30) 
were predictors of 
worse survival. 
Zierer et al., 
2009 (49) 
Retrospective 
study, Level III 
30 mini-AVR 
patients 
compared to 
21 TAVI 
patients. 
EuroSCORE 
predicted risk 
for mortality 
(mini-AVR 
vs SS AVR): 
35±9 % vs 38 
±14 % 
L-Shaped 
partial upper 
sternotomy 
Operative time (min) 
for TAVI vs mini-
AVR:  154±33 vs 
208±28, p=0.004, no 
difference in early 
mortality; ventilation 
time (hours), TAVI 
vs mini-AVR): 6±2 
vs 18±3,p <.001; ICU 
stay (days, TAVI vs 
233 (31.9%) 
had had 
previous 
cardiac 
procedures; 
age, 
preoperative 
comorbidities, 
and 
perioperative 
faster 
postoperative 
recovery after 
TAVI, with 
comparable 
mortality or 
morbidity to mini-
AVR. 
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mini-AVR): 1.0   
±0.4 vs 3.2 ±1.9, 
p<0.001; hospital stay 
(days, TAVI vs mini-
AVR): 5.0±0.9 vs 
12±3.4, p<0.01; no 
difference in re-
explorations, heart 
block rate, pacemaker 
implantation rate, 
stroke, AF. 
EuroSCORE 
matched 
between the 2 
groups. 
Martens et 
al., 2009 
(50) 
Retrospective, 
Level IV 
22 patients, 
age>79, 
sutureless 
mini-AVR 
using 
sutureless 
ATS 3f 
Enable aortic 
bioprosthesis 
Mean logistic 
EuroSCORE 
was 13 
partial upper 
sternotomy 
Valve implantation 
time:10±6 minutes; 
CPB time:87±16; 
AoX: 55±11 minutes; 
early mortality (90 
days) :9% 
(2 patients); no 
paravalvular leaks, 
mean transvalvular 
gradients: at 
discharge and 9±6 
mm Hg, 8±2 mm Hg 
at 1 year 
Concomitant 
subvalvular 
myectomy in 
2 patients. 
Sutureless mini-
AVR in elderly, 
high risk elderly 
patients is 
feasible, safe and 
results in good in 
early and mid-
term 
haemodynamic 
performance. 
Concistre et 
al., 2013 
(51) 
Retrospective, 
Level IV 
13 patients, 
mean age 77 
± 3.9 years, 
sutureless 
mini-aVR, 
ATS 3f 
Enable aortic 
bioprosthesis 
mean, SD 
logistic 
EuroSCORE 
was 
15%±3.5%. 
V-type mini-
sternotomy 
interrupted at 
the second 
intercostal 
space 
mean CPB time: 
100.2 ± 5.3; AoX: 
66.4±18.6 minutes, 
no hospital mortality, 
short term mean ± SD 
pressure gradient: 14 
±4.9 mm Hg (median 
follow-up time was 4 
 
Sutureless mini-
AVR in high risk 
elderly patients is 
feasible, safe and 
with good 
haemodynamic 
results 
  38 
months [interquartile 
range, 2-10 months]) 
Burdett et 
al., 2014 
(52) 
Retrospective, 
Level III 
98 patients 
mini-AVR 
and 93 
patients 
CAVR 
mean logistic 
EuroSCORE 
mini-AVR 
7.15 vs SS 
AVR 6.55, P 
= 0.47). 
manubrium-
limited 
sternotomy 
mean CPB time 
(mini-AVR vs SS 
AVR): 88 vs 78 min, 
p = 0.00040; mean 
AoX (mini-AVR vs 
SS AVR): 66 vs 60 
min, P = 0.0078, less 
postoperative blood 
loss (332 vs 513 ml, p 
= 0.00021); mini-
AVR less likely to 
require blood 
products (24 vs 36%, 
P = 0.042), no 
difference in: length 
of stays, survival, 
need for dialysis for 
AKI, stroke, AF 
rates, PPM rates or 
deep sternal wound 
infection. 
 
mini-AVR 
confers similar 
outcomes to 
CAVR; additional 
benefits with 
mini-AVR in 
reducing blood 
loss and need for 
transfusion. 
Miceli et 
al., 2016 
(53) 
Retrospective, 
propensity 
matched, Level 
III 
37 patients 
mini-AVR 
with Perceval 
S sutureless 
valve 
compared to 
37 TAVI 
group 
mini-AVR vs 
TAVI 
median, IQR 
EuroSCORE:  
14.2 (7.3–
18.7) and 14 
(11.1–21.5) 
respectively. 
right anterior 
mini-
thoracotomy 
in-hospital mortality 
(mini-AVR vs 
TAVI): 8.1% (n = 3) 
vs 0, p=0.25 and no 
difference in stroke 
rates, conversion to 
full sternotomy, 
major bleeding, renal 
No severe 
paravalvular 
leaks in both 
groups 
Mini-AVR with a 
trend of 
better early 
outcomes and 
mid-term survival 
compared with 
TAVI. 
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failure, ICU stay; 
ward stay shorter for 
TAVI group (4.5[3-6] 
vs 7 [6-8]), p<0.01; 
more paravalvular 
leaks in TAVI group 
(p<0.01); no 
difference in 
haemodynamic 
performance, AV 
block rates or PPM 
insertion ates; 1 year 
survival (mini-AVR 
vs TAVI): 91.6 vs 
78.6% and 2 year 
survival: 91.6 vs 
66.2%, p=0.1 
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Table 4 Mini-AVR in patients with poor lung function, pulmonary HTN, poor LV, renal failure and in patient requiring concomitant procedures.  
Abbreviations: AVR- aortic valve replacement; mini-AVR- minimally invasive aortic valve replacement; SS – standard sternotomy; CAVR- 
aortic valve replacement via median sternotomy; CPB – cardiopulmonary by-pass; A0X – aortic cross clamp; IQR – interquartile range; ICU – 
intensive care unit; AKI – acute kidney injury; PPM – permanent pacemaker; AF- atrial fibrillation; COPD – chronic obstructive pulmonary 
disease; FEV1 – forced expiratory volume in 1 second.; TAVI - transcatheter aortic valve insertion; eGFR – estimated glomerular filtration rate.  
High risk 
group 
Author, 
date and 
journal 
Study type 
and level of 
evidence 
Patient 
group 
Outcomes Outcomes Comments Conclusion 
Poor lung 
function 
Santana et 
al., 2012 
(72)  
Retrospective, 
Level III 
165 patients 
undergoing 
isolated 
valve 
surgery who 
had 
diagnosed 
COPD. 100 
patients 
mini-AVR 
vs 65 
patients SS 
AVR.  
mini-sternotomy Of the 165 patients 
with diagnosed COPD, 
in hospital mortality 
(mini-aVR vs CAVR): 
1% vs 5%, p=0.14; 
composite of 
postoperative 
complications reduced 
in mini-aVR (30 
versus 54%, P = 
0.002); median ICU 
stay (mini-AVR vs 
CAVR): 47 h (IQR 
40–70) versus 73 h 
(IQR 51–112), P < 
0.001; median 
postoperative length of 
stay (mini-aVR vs SS 
AVR): days (IQR 5–9) 
composite of 
postoperative 
complications 
included: 
death, renal 
failure, 
prolonged 
ventilation, re-
intubation, 
sternal deep 
wound 
infection, 
sepsis, 
pneumonia, 
bleeding 
requiring re-
operation, 
stroke, atrial 
fibrillation 
In patients with 
diagnosed COPD 
a minimally 
invasive 
approach is 
beneficial in 
terms of length 
of hospital stay 
and reduced 
post-operative 
complications. 
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versus 9 days (IQR 7–
13), P < 0.001; median 
CPB time  (mini-aVR 
vs CAVR): 118 min 
(102–140) vs min 80 
(60–106) <0.001; AoX 
( (mini-aVR vs 
CAVR): 84 (71–102) 
53 (41–74) <0.001, 
more transfusion of 
red blood cells with 
CAVR (p<0.001).  
Albacker et 
al., 2014 
(57) 
Retrospective, 
Propensity 
matched, 
Level III 
223 
propensity-
matched 
pairs of 
patients with 
measured 
FEV1%: 
mini-aVR 
versus 
CAVR 
identified 
from 6931 
consecutive 
isolated 
AVRs.  
partial upper J-
incision 
patients with chronic 
lung disease had a 
longer median ICU 
stay (41 vs 27 hours, 
p=0.001) and 
postoperative length of 
stay (7.1 vs 6.1 days, 
P<.0001); at normal 
values of FEV1% no 
difference between 
mini-aVR and CAVR 
however at 
progressively lower 
FEV1% length of stays 
were shorter with 
mini-AVR; trend 
toward better survival 
with mini-AVR 
(93%vs 89%at 1 year, 
p=0.07) but survival at 
 Patients with 
poor pulmonary 
function pre-
operatively 
would benefit 
from mini-AVR 
in terms of ITU 
length of stay 
and overall 
length of hospital 
stay; better 
survival with 
mini-AVR as 
lung function 
decreases.  
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5 years was no longer 
different (p=0.9), 
greatest survival 
advantage persisting at 
5 years in patients with 
FEV1%<50.  
Pulmonary 
HTN 
Gosain et 
al., 2016  
(59) 
Retrospective, 
Level III 
569 patients 
(mean age 
72±11) 
following 
minimally 
invasive 
aortic/mitral 
valve 
replacement 
with mild to 
severe 
pulmonary 
HTN. 
Right mini-
thoracotomy 
mild/moderate 
pulmonary HTN 
(n=474) vs severe 
pulmonary HTH 
(n=95): no difference 
in operative mortality, 
postoperative stroke 
rates; need for 
intraoperative 
transfusion or 
ventilation times; ICU 
length of stay shorter 
for mini-AVR (46 ± 10 
vs 70 ± 12, p<0.001) 
bur no difference in 
hospital length of stay 
(p=1).  
mean 
pulmonary 
artery pressure 
(mPAP) was 
classF4:G4ified 
as mild (mPAP 
25-29mmHg), 
Moderate (30-
39mmHg), 
Severe (mPAP 
>39mmHg) 
Mini-AVR safe 
and feasible in 
patients with PH. 
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Renal 
dysfunction  
Valdez et 
al., 2013 
(63) 
Retrospective, 
Level III 
688 patients 
with chronic 
kidney stage 
2 to 5 who 
underwent 
either 
minimally 
invasive 
valve 
surgery 
(510, 
74%).or 
conventional 
valve 
surgery 
(178, 26%) 
Right mini-
thoracotomy for 
mini-AVR and 
left mini-
thoracotomy for 
mitral valve 
surgery.  
less composite 
complication with 
mini-AVR: (33.1%vs 
49.4%; odds ratio, 0.5; 
p≤0.001); shorter 
intensive 
care unit (48 [IQR, 33-
74] hours vs 71 [IQR, 
42-96] hours; p<0.01); 
hospital stay (8 [IQR, 
6-9] days vs 10 [IQR, 
8-15] days; p<0.001); 
lower incidence of 
acute kidney injury 
(8%vs 14.7%; odds 
ratio, 0.5; P ≤ 0.01); in 
multivariable analysis, 
minimally invasive 
valve surgery 
associated with a 60% 
reduction in the risk of 
postoperative acute 
kidney injury 
composite of 
complications 
included: AF, 
pneumonia, 
reintubation, 
stroke, sepsis, 
wound 
infection, 
prolonged 
ventilation, 
bleeding 
requiring 
reoperation. 
+F5:G5 
minimally 
invasive valve 
surgery for 
patients with pre-
existing CKD 
stage 2-5 
associated with 
reduced 
postoperative 
complications 
and risk of acute 
on chronic renal 
failure.  
 
Haldenwang 
et al., 2014 
(64) 
Retrospective, 
Level III 
70 patients, 
age>75 
years, 
undergoing 
TAVI vs 56 
mini-AVR 
“J”-shape 
sternotomy 
58 patients developed 
a risk of AKI 
(Creatinine > 03 
mg/dL or 1.5–1.9-fold 
creatinine increase 
from baseline) and 13 
had renal injury or 
failure (>2-fold 
creatinine increase 
EuroSCORE II 
and 
preoperative 
creatinine 
higher for 
TAVI vs mini-
AVR (p<0.01), 
eGFR higher in 
in mini-aVR 
A higher risk for 
AKI after TAVI 
should be 
considered in 
elderly patients.  
  44 
from baseline): higher 
AKI risk for TAVI 
(odds ratio, OR=2.58; 
95% confidence 
interval, CI=1.18, 
5.63; p=0.017), no 
correlation between 
AKI and early 
mortality. 
patients 
(p=0.01) but 
these 
parameters had 
no impact on 
AKI on further 
analysis 
(logistic 
regression).  
Poor LV Tabata et 
al., 2007 
(65) 
Retrospective, 
propensity 
matched, 
Level III 
140 patients 
with ejection 
fraction 
≤40% 
undergoing 
isolated 
AVR: 73 
patients 
mini-AVR 
and 67 
CAVR.  
Upper hemi-
sternotomy 
operative mortality 
was comparable 
between mini-AVR 
and CAVR (2.4% vs 
4.8%, p=0.562); no 
difference in: CPB 
time, AoX times, 
reoperation for 
bleeding, blood 
transfusion 
requirement, 
ventilation times, 
perioperative MI, renal 
failure, 
cerebrovascular 
events, deep sternal 
wound infection or 
length of hospital stay, 
or discharge to home 
rates 
 
mini-AVR in 
patients with 
poor left 
ventricular 
function can be 
performed safely 
with comparable 
results to CAVR.  
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Mihaljevic 
et al., 2014 
(66) 
Retrospective, 
Propensity 
matched, 
Level III 
matched 
pairs of 
patients with 
NYHA class 
III-IV who 
underwent 
minimally 
invasive 
valve 
surgery 
(n=185) vs 
185 pairs 
conventional 
surgery; 
further 
adjustment 
for surgeons: 
139 
minimally 
invasive 
valve 
surgery vs 
138 
conventional 
surgery.     
Upper hemi-
sternotomy 
minimally invasive 
surgery versus 
conventional 
sternotomy provided 
shorter AoX time 
(59±27 vs 64±26 
minutes), CPB time 
(75±35 vs 86±34), 
ICU stays (24 vs 43 
hours, p=0.007); 
hospital morbidity, 
mortality, long-term 
survival were similar; 
after adjusting for 
surgeon: all outcomes 
were similar, including 
AoX times, CPB 
times, ICU, hospital 
stays and survival.  
mixed aortic 
and mitral 
surgery 
In patients with 
poor LV a 
minimally 
invasive 
approach 
provides 
comparable post-
operative results 
when compared 
to median 
sternotomy 
approach. 
Obese 
patient 
Santana et 
al., 2011 
(58) 
Retrospective, 
Level III 
160 obese 
patients with 
(body mass 
index of 
greater than 
30 kg/m2) 
undergoing 
Right 
minithoracotomy 
composite 
postoperative 
complications: 15 
(23.49%) versus 49 
(51.0%), p=0.034, in 
the minimally invasive 
group versus median 
mixed aortic 
and mitral 
surgery 
Minimally 
invasive surgery 
in obese patients 
has a lower 
morbidity and 
mortality when 
compared with 
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isolated 
valve 
surgery: 64 
underwent 
minimally 
invasive 
isolated 
valve 
surgery 
compared to 
96 via 
conventional 
surgery 
sternotomy; minimally 
invasive valve surgery 
associated with: lower 
incidence of acute 
renal failure (0 vs 6 
patients [6.25%], p   
0.041), shorter 
ventilation times: 
prolonged intubation 
(12 [18.7%] vs 33 
[34.3%], p=0.049); 
lower reintubation 
rates (3 [4.68%] vs 15 
[15.6%], p=0.032), 
less deep sternal 
wound infections: (0 
vs 4 [4.1%], p=0.098), 
and death (0 vs 8 
[8.3%], p   0.041). 
conventional 
surgery.  
 
Acharya et 
al., 2016 
(68) 
Retrospective, 
Level III 
90 patients 
receiving 
mini-AVR. 
Univariate 
linear 
regression 
analysis 
performed to 
examine the 
effects of 
BMI (≥25 vs 
<25) on 
post-
J-shaped 
sternotomy 
overall no peri-
operative mortality, 
myocardial infarction 
or stroke; patients with 
BMI≥25 had: longer 
AoX times (p=0.0218), 
trend towards longer 
CPB times (p=0.0615), 
higher incidence of 
hospital acquired 
pneumonia (p=0.020) 
and new onset of AF 
(p=0.036); no effect of 
single arm 
study design 
mini-aVR can 
reduce obesity 
related 
complications 
  47 
operative 
outcomes.  
raised BMI on ICU 
and hospital stays; 
similar rates between 
groups of infection, 
inotrope requirements 
and renal dysfunction; 
increasing BMI 
correlated with 
reduced mechanical 
ventilation (p = 0.039) 
and blood loss (p = 
0.004). 
Concomitant 
procedure 
Totaro et 
al., 2009 
(69) 
Retrospective, 
Level III 
1126 
procedures 
minimally 
invasive 
aortic 
procedures: 
695 patients 
undergoing 
isolated 
aortic valve 
surgery 
(61%) vs 77 
patients who 
had re-do 
mini-AVR 
vs complex 
procedures 
performed in 
in 354 
(32%).     
Upper mini-
sternotomy 
overall in-hospital 
mortality was 4.1%; 
complex minimally 
invasive surgery 
associated with 
significantly higher 
postoperative mortality 
(24 patients, 6.7%) 
than isolated 
procedures or re-do 
min-aVR; ventilation 
times (p<0.05), ICU 
stays (P<0.05) and 
bleeding (p<0.05) 
higher for complex 
group vs isolated or re-
do groups; hospital 
stay longer for 
complex groups vs 
isolated AVR (p<0.05, 
complex 
procedures 
included: 
double valve 
replacement-
repair, 
ascending 
aorta-aortic 
arch 
replacement, 
aortic root 
replacement, 
aortic 
dissection, 
AVR combined 
with coronary 
surgery, and 
complex redo 
procedures.  
Minimally 
invasive 
approach for 
complex 
procedures safe 
and feasible.  
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no differences in 
conversion to full 
sternotomy or surgical 
revision across the 3 
groups.   
 
Elmahdy et 
al., 2010) 
(71) 
Retrospective, 
Level IV 
6 patients 
undergoing 
minimally 
invasive 
triple valve 
surgery 
patients: 5 
mini-AVR 
and 1 
minimally 
invasive 
aortic valve 
repair 
combined 
with 
tricuspid 
valve repair 
and mitral 
valve repair.  
right anterior 
thoracotomy 
approach 
2 early deaths; 2 
patients had new onset 
of AF; no 
postoperative 
cerebrovascular 
accidents, myocardial 
infarctions or acute 
kidney injuries; 
median ICU stay: 62 h 
(IQR: 50-111 h); 
median hospital stay: 
12 days (IQR: 7-23 
days) 
 
Minimally 
invasive triple 
valve surgery 
safe and feasible.  
 
Kaneko et 
al., 2012 
(70) 
Retrospective, 
Level III 
109 patients 
undergoing 
mini-AVR 
combined 
with aortic 
surgery.  
Upper hemi-
sternotomy 
operative mortality 
was 2.8% (n = 3); 4 
(3.7%) reoperations 
for bleeding; mean 
CPB time: 152 ±61 
minutes; AoX time: 
single arm 
study design; 
associated 
aortic 
procedures 
included: supra 
Mini-AVR 
combined with 
aortic surgery is 
safe and feasible 
and associated 
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108±47 minutes; 2 
(1.8%) myocardial 
infarctions, 2 (1.8%) 
new-onset renal 
failure; mean length of 
stay was 7.1±5.6 days; 
1-year survival was 
96.2% and 5-year 
survival was 92.4%;  
coronary 
ascending 
aortic 
replacement 
(n=65), 
ascending and 
proximal arch 
replacement, 
(n=8 patients), 
aortoplasty 
(n=11 
patients), 
Bentall 
procedure 
(n=8), root 
enlargement 
(n=13)  
with good early 
outcomes.  
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